6/28/2024Walvax and Abogen Terminate Collaboration on mRNA Vaccine Development

6/27/2024Novo Nordisk to Limit Wegovy Sales in China amid Supply Shortage

6/27/2024CASI Receives China Business Buyout Proposal from Its Chairman & CEO

6/26/2024New Research Center to Accelerate Drug Approvals in Mainland China Usi...

6/25/2024Takeda to Keep Scouting for Chinese Biopharma Partnerships

6/25/2024Ascentage Files Plan with SEC for Potential Dual Listing in the U.S. a...

6/25/2024Fosun to Take Henlius Biotech Private in HK$13.37B Bid

6/21/2024Review of Chinese Drug Market Performance of Seven Leading MNCs 2016-2...

6/20/2024Biocon Eyes China for Generic Diabetes and Weight-Loss Drug Trials

6/20/2024Fosun to Reduce Its Stake in India's Gland Pharma

6/19/2024Tencent Bets on China Healthcare as Needs Grow

6/19/2024Day One Biopharma Nabs ex-China Rights of MabCare's ADC MTX-13

6/18/2024RecoRNA Biotechnology and Starna Therapeutics Enter Strategic Partners...

6/14/2024Livzon Seeks Approval for Generic Version of Novo Nordisk's Ozempic

6/14/2024Takeda, Ascentage Enter into Global License Deal for Olverembatinib

6/13/2024AbbVie and FutureGen Enter License Deal to Develop Next-Gen Therapy fo...

6/13/2024Ethypharm Expands Its Mesalazine (Etiasa) Portfolio in China 

6/12/2024WuXi PharmaTech Buoyed Amid Uncertainties on BIOSECURE Act's Legislati...

6/7/2024InDevR and Sino Biological Partner to Deliver Multiplexed Solutions fo...

6/7/2024Korean Pharma Booms as U.S. Cuts Ties with Chinese Partners

6/7/2024Ipsen and Marengo Announced Second Strategic Partnership to Advance P...

6/7/2024Novo Nordisk Faces Stiff Generic Competition in China’s Weight-Loss D...

6/5/2024ArriVent Enters a Multi-Target ADC Deal with Alphamab

6/5/2024Bristol Myers Squibb Signs Clinical Trial Agreement with I-Mab

6/4/2024HuidaGene and Synthego Announce Licensing Deal on Next-Generation Gene...

6/3/2024Sales Expenditures of Chinese Pharma Cos Continued to Grow But Lagging...

6/3/2024Fosun Reportedly Weighing Buyout of Henlius Biotech: Bloomberg

5/29/2024SGD Pharma Invests €20M in Chinese Facility

5/29/2024Bio-Thera and STADA Enter Exclusive Deal for BGolimumab Biosimilar in ...

5/27/2024Review of R&D Spending of A Share-Listed Chinese Pharma Cos in 2023

Page:19/21 Total number of articles:605: [First][<<] [17] [18] [19] [20] [21] [>>] [End]